chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Unable to move right arm 5 days later, limited range of motion and unable to lift or raise. Pain in right arm that is not subsiding. After vaccine I experienced arm pain, fever and chills x 2 days. All other symptoms have subsided except for the right arm pain, strength and mobility.
30 minutes after HPV #1, developed tightness to throat, and SOB. No stridor, vocie OK. Seen in ER given .3cc 1:1000 IM adrenaline, IV BENADRYL 50 mg, ZANTAC 50 mg IV and SOLUMEDROL 125 mg IV felt better PT. seen at hospital.
Received vaccine on a thursday, on Sunday had a reaction after eating (all foods had been previously eaten with no adverse effects). Had severe diarrhea, cramping, facial and throat swelling and passed out. Was eventually transported to hospital via ambulance and diarrhea progressed to bloody diarrhea. Discharge summary states dehydration, hypokalemia. msv
Rash on front left shoulder - same side as injection. Cluster of red bumps. Not itchy. Lasting several days. Swollen pea sized lymph node on left side of neck.
Patient with syncope post injection. Patient regained consciousness about 5-6 seconds after syncopal event. Alert and oriented x3. Had patient remain in supine position for 5 min, then allowed her to sit up in the chair. Patient given graham crackers and Sprite to drink. BP: 110/66, P: 72. Patient waited a total of 30 min in the office post event prior to leaving.
Rash Post Second Dose (Neck, Chest and Under Breast); Fever 99.5F Post Second Dose; Chills Post Second Dose; Sore Left Arm Post Second Dose; Sore Left Armpit Post Second Dose; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore Left Arm Post Second Dose), AXILLARY PAIN (Sore Left Armpit Post Second Dose), RASH (Rash Post Second Dose (Neck, Chest and Under Breast)), PYREXIA (Fever 99.5F Post Second Dose) and CHILLS (Chills Post Second Dose) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore Left Arm Post Second Dose), AXILLARY PAIN (Sore Left Armpit Post Second Dose), PYREXIA (Fever 99.5F Post Second Dose) and CHILLS (Chills Post Second Dose). On 05-Feb-2021, the patient experienced RASH (Rash Post Second Dose (Neck, Chest and Under Breast)). At the time of the report, PAIN IN EXTREMITY (Sore Left Arm Post Second Dose), AXILLARY PAIN (Sore Left Armpit Post Second Dose), RASH (Rash Post Second Dose (Neck, Chest and Under Breast)), PYREXIA (Fever 99.5F Post Second Dose) and CHILLS (Chills Post Second Dose) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-021396 (Patient Link).
Swelling of her arm where she got the shot; didnt hurt at all. Went to bed, in the morning swelling reduced and disappeared by next day. The swelling was in the upper part of arm.
1 week and 2 days after injection: 1) burning 2) Itching 3) temperature of injection site went up to 102 within a 1 CM area 4) body temp was spiking the next morning after it started developing 5) I didn?t sleep well that first night. Was sweating and cold cycling 6) pounding headache 7) arm was swollen and radiating heat 8) painfully sensitive to touch and pressure
Syncopal episode x about 1 min followed by convulsions x 30 seconds following 2nd shot of GARDASIL. Resolved spontaneously. Sx improved after water and lying down in supine position.
Macular papular (some confluent) pruritic rash all over body; most on trunk. Temp 101, fussy, drooling, alert, poor appetite.
Patient presented to the ED and was subsequently hospitalized for hyperkalemia and renal failure within 6 weeks of receiving COVID vaccination.
Arm painful red, swollen warm to touch. Seen in walkin care 6-26-10, ice-BENADRYL. Symptoms resolved.
Pt seemed somewhat anxious prior to injection.  Had been sitting in observation x 13 min. and states felt light headed and fell out of chair onto floor . pt was immediately assisted. was not responsive initially, pulse present at 64,  pt was responsive within 30 sec to her name, denies any pain, alert and oriented x 3, skin clammy, denies sob, and no sob,  states has not ate today and has drank very little fluids today.  motor skills good and pupils equal,  moves all extremities,  bump to left side of posterior head approx half dollar size, no bleeding noted, c/o nausea,   911 called and pt assisted to sit up but c/o feeling like she will pass out again,  B/p 130/82 assisted to cot, medics notified of hx of thrombocytopenia. ice pack and cool cloth to head and neck. Pt transferred to hospital and husband here.
Rash started on r forearm and spread to left arm am currently spreading to chest and legs; Blisters, what looks like calcium splinters and skin peeling; Peeling skin with pain in joints; This is a spontaneous report received from a contactable consumer (patient). A non-pregnant 66-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1, via an unspecified route of administration, administered in the left arm on 29Mar2021 at 13:00 (Lot Number: LAB-1451-0.7), at the age of 66 years, as a single dose for COVID-19 immunization.  Medical history included myasthenia gravis, mixed auto immune diseases, allergies to Valium and Zofran. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medication taken within two weeks of vaccination included omeprazole, alprazolam, levothyroxine, rivaroxaban (XARELTO), losartan potassium (LOSARTIN), atorvastatin, amlodipine, fluticasone, albuterol (SALBUTAMOL). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, at 12:00 am, the patient developed rash started on (R) forearm and spread to left arm and currently spreading to chest and legs. Blisters, what looks like calcium splinters and skin peeling, peeling skin with pain in joints. The events were reported as non-serious. The events required a physician office visit. No treatment was given for the events. The clinical outcome of the events was not recovered.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Vasovagal Syncope... per husband patient had a history of  previous events  after vaccines (apparently had shot anxiety)... No other reaction presented. no need for Epi-pen... We had call emergency services, to assist the patient as well.
received the  first Pfizer Covid shot on March 18, 2021 and on March 31, 2021, in the evening after taking a shower, I experience brain fog. I have never experience brain fog before. I could not recall what I had done that hours prior to experiencing this brain fog. It wasn't until I sat down with a pen and paper that  I was able to recall the events of the day.  I do not take drugs of any kind. This event lasted about 20 minutes.  On April 8, 2021 I received my second Pfizer Covid shot and on April 24, 2021 at about 7pm I experience brain fog again.  Again I took a piece of paper and pen and wrote down what I had done that day because again I could not remember what I had done. It took about 20 minutes for me to be able to recall the events of the day.   It is now August 4, 2021 and I have not had any additional episodes of brain fog. I have never had brain fog before. I don't drink, smoke or take any drugs, medication, except for the occasional vitamin.    During the episodes I knew who I was and where I was, but timewise, I was unable to orient myself. I couldn't figure out where in the day I was. I was able to piece things together eventually.
Pain, aching, itching. Gradual increased swelling. Rash-erythema 4cm x 11cm warm raised. Possible secondary cellulitis. 12/9/15 Treatment: oral antihistamine (BENADRYL), KEFLEX 500mg one tid x10 days. 12/11/15 Added: ZYRTEC 10mg one qid, topical hydrocortisone.
Flu like symptoms: fever, body aches, chills, fatigue and weakness, headaches, dry mouth Large red rash at injection site with stiff arm. Shortness of breath  Sensitivity to bright flashing lights   Pain at the jaw / molar area  Joint pain
Dose 1; 1/15/21; About 8 hrs post, itching/rash upper body; 1/16/21, Itching and on and off dizziness; 1/17/21 Itchy on and off dizzy; 1/18/21; Trip to ER dizzy, nauseous vertigo.
Pt recvd Rubella vax 13AUG91 & became ill on 23AUG fever & sore throat; rash faint red on face, neck, back, chest on 24AUG to 26AUG;
Left deltoid pain; afterwards generalized joint and bone pain (next day); fatigue and tiredness. No treatment. Second dose of vaccine administered on 08/29/2013.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Headache-Mild, Additional Details: Patient was very honest with me before giving the shot that she has a condition in which every time she receive any injection she does faint. Her husband was with her at the time. I used my best judgement and still give her the shot. 2minutes not related to the vaccine in my opinion but patient threw up and was dizziness. water was offered and 911 was called as a precaution. Shortly after dispatcher arrived she was actually fine and no further action was necessary.
BLOOD CLOT; ARM SORENESS; TIREDNESS; This spontaneous report received from a patient and concerned a 36 year old  female. The patient's weight was 177 pounds and height was 165 centimeters. The patient's past medical history included fibroid surgery (fibroid was taken out 2 months), and concurrent conditions included alcohol drinker (once a week - occasionally), non-smoker, no drug abuse or illicit drug use, no known allergies. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, intramuscular (right deltoid), batch number: 043A21A) dose was not reported, administered on 05-APR-2021 for prevention of covid-19 disease. No concomitant medications were reported.  On 05-APR-2021, an unspecified amount of time after vaccination, the patient experienced arm soreness and tiredness that resolved within 3 days.  On 15-APR-2021, 10 days after vaccination, the patient experienced calf pain and blood clot. It was reported the patient felt a very sharp pain on her right calf while walking, pain scale was 8/10, and it was so painful that she could not put pressure on it. Therefore, she decided to go to the hospital to have it checked. Her attending physician confirmed based on ultrasound that she has a blood clot on her right leg. She was prescribed blood thinner Eliquis (apixaban) however she was still undecided because her insurance denied to cover it and it was out of pocket. Once she returned home, she stated that the sharp pain was gone and it was just achy. After conversation with her physician, her physician postponed the medication for now because he wanted to make sure that her blood was not already thin before prescribing a blood thinner. She will go to the hospital again on 16-APR-2021 to see a hematologist for blood works and her physician advised her not to work until 20-APR-2021 as a preventive measure. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from arm soreness, and tiredness on 08-APR-2021 and had not recovered from blood clot. This report was serious (Other Medically Important Condition, and Life Threatening).; Sender's Comments: V0:  a 36-year-old female experienced a blood clot in her right leg, 10 days after receiving the Janssen COVID-19 vaccine for prevention of COVID-19 infection.  The patient is a non-smoker, her BMI is 34.5; she has no other relevant medical history and reported no concomitant medications.    Ten days after receiving the vaccine, she felt a sharp pain, graded 8/10, in her right calf while walking.  Ultrasound showed a blood clot on her right leg.  She was prescribed Eliquis but did not fill the prescription and the pain subsided; she was to have further blood tests and see a physician the following day.  Additional information is being sought.
I was not feeling good, The 2nd day after my vaccine I had chills, sweats and my body was tired. I woke up feeling my whole body dry I needed to water, I wasn't feeling any movement in my body I passed out, i hit my head and when I woke up I couldn't move my body my friend took me to hospital. I was in lots of pain. They examined me gave me medicine and sent me home, My whole body was swelling and i could not walk. My dr put me on pain meds and Humira and prednisone.
Patient felt sweaty, throat felt is was closing.   This started 15-20 minutes after the vaccine was administered EMS was called, but patient was feeling better and did not want to go  the hospital so she refused service . She sat for about 40 minutes before she left
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On or about 16-DEC-2013, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 31-DEC-2013, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster with nervous system complications. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
lips felt tingle; tongue dexterity affected; tongue became sensitive to eventoothpaste; tongue felt thickened; Very dry mouth; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206), via an unspecified route of administration in the left arm on 04Mar2021 at 11:00 (at the age of 77-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure and cholesterol. Concomitant medication included amlodipine (MANFACTURER UNKNOWN) and simvastatin (MANFACTURER UNKNOWN); both for unknown indications from unknown dates. The patient did not have allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Mar2021 at 17:00 (after 4+ hours receiving the first dose), the patient's lips felt tingle and her tongue dexterity affected and tongue became sensitive to even toothpaste, tongue felt "thickened" although no problem in swallowing. The patient also had very dry mouth. The patient took BENADRYL as a therapeutic measure, symptoms persisted but lessened, she was apprehensive about taking second dose. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lips felt tingle, tongue dexterity affected, tongue became sensitive to even toothpaste, tongue felt thickened and dry mouth was resolving.  No follow-up attempts are needed. No further information is expected.
Chills, heavy arms and legs, achy. Pretty bad the 15th. Same thing the next day but started at 8:30 pm. Had just tired and yucky feeling for another week. Took Tylenol.
C/O L arm tingling down to finger tips. (equal grip bilat and 1-2 sec cap refill). C/O headache, facial expressions symmetrical, clear speech. Mom called, states pt ok to stay in class. Mom will call pediatrician.
Information has been received from a health professional concerning a 40 year old HIV (+) male "new pt to the physician's practice" with no known drug allergies who on 4/19/02 was vaccinated with his 1st dose of Hep-A, in the left deltoid (lot 639844/0924L). The health professional indicated that she did not believe the pt was on any concomitant therapy. On 4/23/02, the pt returned to the physician's office with left-sided facial paralysis and numbness which had developed on 4/21/02. The pt was treated with ibuprofen, methylprednisolone acetate (Depo-Medrol) and valacyclovir hydrochloride (Valtrex). On 4/30/02, the pt returned to the physician's office with continued facial pain and a drawn mouth. Follow-up information from the health professional indicated that on 5/7/02, she "worked the pt up" prior to him being seen by the physician. The pt reported to her that his left-sided facial paralysis was a "little better" and that he could move his mouth. The pt did not report on the facial pain or numbness. The pt's numbness, facial pain and drawn mouth have continued. The health professional indicated that the physician felt that the left sided facial paralysis, numbness, drawn mouth and facial pain were related to therapy with Hep-A virus vaccine inactivated. Additional information has been requested. The physician reported that as of 5/7/02, the patient was improving and as of 5/22/02 the patient had not recovered. Upon internal reveiw, the patient's Bell's Palsy/left sided facial paralysis was considered an other medical event. No addtional information is expected.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 12:02 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 12:02 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 50.46.  Concomitant products were not provided.  On 03-Apr-2021, At excursion time 09:00 AM, temperature was 34, total doses given for the day was 210 condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 30-Mar-2021, vial was moved to clinic on 03-Apr-2021. 20 vials were sent to clinic. Vaccine BUD date was 29-Apr-2021.  Vial was stored on cooler 1, on 03-Apr-2021, Excursion duration At 8 AM: 38, 9 AM: 34, 10 AM: 38, 11 AM: 42, 12 PM: 41, 1PM: 41, 2 PM : 41, 3 PM: 40, 4 PM: 40 and 5 PM : 41.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a  traceable temperature monitor at every hour. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
HEADACHE; This spontaneous report received from a consumer concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow up to request batch number. No concomitant medications were reported. On an unspecified date, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache. This report was non-serious.
injection site pain; Migraine headache; Chills; Achiness; Exhausted; less of agility; could not keep her eyes open; condition aggravated.; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included sumatriptan tablet for migraine.   Concurrent medical conditions included migraine (Migraine headache).   On 17th April 2019, the patient received the 1st dose of Shingrix. On 18th April 2019, the patient started sumatriptan (oral) 50 mg at an unknown frequency. On 17th April 2019, immediately after receiving Shingrix and an unknown time after starting sumatriptan, the patient experienced injection site pain, migraine headache, chills, pain, exhaustion, feelings of weakness, sleepiness and condition aggravated. The patient was treated with sumatriptan (Imitrex). On 18th April 2019, the outcome of the migraine headache, chills, pain, exhaustion, sleepiness and condition aggravated were recovered/resolved. On an unknown date, the outcome of the injection site pain was not recovered/not resolved and the outcome of the feelings of weakness was unknown.   It was unknown if the reporter considered the injection site pain, migraine headache, chills, pain, exhaustion, feelings of weakness, sleepiness and condition aggravated to be related to Shingrix.  Additional details were provided as follows: The patient received 1st dose of Shingrix in the left arm, on 17th April 2019 at around 11:30am. 8 hours and 30 minutes after vaccination with Shingrix, the patient experienced with exhaustion and sleepiness. Less than a day after vaccination, the patient experienced migraine headache, chills and pain. On 18th April 2019 at 10:30pm, less than a day after receiving Sumatriptan, the patient recovered with migraine headache. The patient stated that, it took longer than normal, but usually it took 1.5 hours for her migraine headaches to resolve after taking the generic product. The reporter did not consent to follow up. The reporter was unable to provide any additional information.